APP and Alzheimer disease: In AD pathogenesis, GPCRs are found to be associated with various stages of APP proteolysis, which includes modulation of APP processing by the α-, β- and γ-secretases and regulating degradation of Aβ and Aβ-mediated toxicity (Thathiah and De Strooper, 2011; Wisely et al., 2014).